Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Researchers at the Kennedy Institute and the University of York develop a new imaging approach that offers superior resolution to track the movement of soluble proteins in tissues.

Illustration Showing new Method to Study the Behaviour of Soluble Molecules in Tissues

Soluble proteins help to correctly position immune cells in tissues and throughout the body to optimise immune defense. Up until now visualising the precise movement of these proteins has been tricky because different molecules of the same protein display variable patterns of diffusion. Profs Mark Coles, Mark Leake (University of York) and colleagues now report a new high-speed light microscopy approach that allows tracking of single molecules with multimodal mobility patterns.

Speaking of the work, Mark Coles said "By developing a novel imaging system to directly image how these chemoattractive molecules move in tissues we will be able to better understand how to target these molecules in rheumatological disease".

Then current study focuses on a certain type of proteins called chemokines that guide the migration of cells in tissues. But the authors suggest their imaging approach could be used to study many different signalling proteins and lipids that contribute to inflammatory and degenerative diseases.

Mark Coles is funded by the Kennedy Trust for Rheumatology Research and the research was supported by the Biological Physical Sciences Institute, the Medical Research Council, the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.

Similar stories

How an 'optional' amino acid is required for an optimal immune response

A new study conducted by researchers at the Kennedy Institute of Rheumatology has uncovered a pivotal role of asparagine metabolism in regulating B cell homeostasis and immune response.

No link found between patient genetics and response to anti-IL17 therapy

A new study looked at the effect of patient genetics on their response to secukinumab, an anti-IL17 therapy commonly used to treat inflammatory conditions including arthritis and psoriasis. No link was found between a patient’s genetic variants and their response to therapy. This study challenges the idea that genetics might significantly account for the variable responses to anti-IL17 therapy seen in the clinic.

Newly discovered cells could be responsible for atherosclerosis complications

A new type of macrophages recently identified in atherosclerotic lesions could provide a missing link in understanding the inflammatory origins of the common yet fatal condition.

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

A team led by Alex Clarke at the Kennedy Institute has identified how high mitochondrial activity regulates antibody responses crucial for immunity but is also necessary for the development of lymphoma.

Shifting the dogma about synovial lining macrophages: the early drivers of rheumatoid arthritis

Insights into a specific macrophage population suggest that these cells could drive inflammation in rheumatoid arthritis. Understanding their complex role could lead to better treatments for patients.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity